Angiotensin Receptor Inhibitors

AT1 Receptor

AT2 Receptor

Angiotensin Receptor Inhibitors, Agonists, Antagonists, Modulators & Chemicals

Product Name	AT1 Receptor	AT2 Receptor	Purity
Angiotensin II human	AT1 Receptor	AT2 Receptor	99.96%
Losartan	AT1 Receptor		99.67%
Angiotensin II human acetate	AT1 Receptor	AT2 Receptor	99.79%
Telmisartan	AT1 Receptor		99.81%
Talfirastide	AT1 Receptor		99.91%
Buloxibutid	AT1 Receptor, Ki: >10 μM	AT2 Receptor, Ki: 0.4 nM	99.06%
Losartan potassium	AT1 Receptor		99.91%
PD 123319 ditrifluoroacetate		AT2 Receptor	99.81%
Azilsartan medoxomil	AT1 Receptor		99.88%
Talfirastide acetate	AT1 Receptor		99.87%
Olmesartan medoxomil	AT1 Receptor		99.67%
Azilsartan	AT1 Receptor		99.51%
Angiotensin II human TFA	AT1 Receptor	AT2 Receptor	99.88%
TRV055 hydrochloride	Angiotensin II Type 1		98.69%
(Sar1,Ile4,8)-Angiotensin II	Angiotensin II Type 1		98.69%
TRV055	Angiotensin II Type 1		98.87%
GSK1820795A	AT1 Receptor, IC₅₀: 0.006 μM		99.76%
Fimasartan	AT1 Receptor		98.55%
Losartan-d₄	AT1 Receptor		≥99.0%
Valsartan-d₉	AT1 Receptor		99.33%
Olmesartan methyl ester	AT1 Receptor
Olmesartan-d₄	AT1 Receptor		98.83%
Allisartan isoproxil	Angiotensin II Type 1
Azilsartan medoxomil monopotassium	AT1 Receptor
Olmesartan-d₆	AT1 Receptor
EMD 66684	Angiotensin II Type 1, IC₅₀: 0.7 nM
AT2R antagonist 1		AT2 Receptor
Olmesartan medoxomil (Standard)	AT1 Receptor
Olmesartan medoxomil-d₆	AT1 Receptor
Elisartan	AT1 Receptor

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)	站点地图隐私声明
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.	沪ICP备15051369号-4

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)

姓名
邮箱 *

Sorry, but the email address you supplied was invalid.